Stay updated with breaking news from Impax Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA has posted an Addendum to Briefing Document on its website that was circulated to members of the AdCom ... | May 9, 2023
The attorneys who secured a $145 million settlement for direct purchasers of Endo Pharmaceuticals's Opana ER who said they overpaid generic-drug maker Impax Labs for the prescription painkiller because of a pay-for-delay deal will walk away from the litigation with more than $50 million for their trouble.